I-Mab ADR (NASDAQ:IMAB) does about 366.75K shares in volume on a normal day but saw 1678511 shares change hands in the recent trading day. The company now has a market cap of 193.40M USD. Its current market price is $2.45, marking an increase of 6.99% compared to the previous close of $2.29. The 52 week high reached by this stock is $2.68 whilst the lowest price level in 52 weeks is $0.60.
The consensus objective for the share price is $5.40, suggesting that the stock has a potential upside of 54.63% over the period.
FactSet Research has provided data showing that 2 brokerages have issued ratings for the stock. 0 analysts have rated it as a sell, while 0 advise that it is a overweight. 2 analysts have rated it as a buy and 0 have advised that investors hold their positions. The consensus recommendation rating is Buy and Wall Street’s advice is for investors to Strong Buy the stock.
The company shares received a number of brokerage firm price updates over the past month, with the latest being on December 09, 2021 when Siebert Williams Shank initiated the stock to “Buy” and issued a price target of $96. Needham initiated its price target at $75.
The current price level is 98.54%, 149.11%, and 136.31% away from its SMA20, SMA50, and SMA200 respectively, with the IMAB price moving below the 50-day SMA on current market day. I-Mab ADR (IMAB) stock is up 87.02% over the week and 175.28% over the past month. Its price is 188.24% year-to-date and 30.32% over the past year.
To reach the target analysts have set, the stock logically needs to grow 54.63 percent from here.
Outstanding shares total 78.94M with insiders holding 11.18% of the shares and institutional holders owning 29.54% of the company’s common stock. The company has a return on investment of -28.09% and return on equity of -22.38%. The beta has a value of 1.19. Price to book ratio is 1.01.
